Development of covalent probes to capture<i>Legionella pneumophila</i>effector enzymes
Abstract Upon infection of host cells,Legionella pneumophilareleases a multitude of effector enzymes into the cells cytoplasm that hijack a plethora of cellular activities, including the hosts ubiquitination pathways. Effectors belonging to the SidE-family are involved in non-canonical serine phosphoribosyl ubiquitination of host substrate proteins contributing to the formation of a Legionella-containing vacuole that is crucial in the onset of Legionnaires’ disease. This dynamic process is reversed by effectors called Dups that hydrolyse the phosphodiester in the phosphoribosyl ubiquitinated protein. We installed reactive warheads on chemically prepared ribosylated ubiquitin to generate a set of probes targeting these Legionella enzymes. In vitro tests on recombinant DupA revealed that a vinyl sulfonate warhead was most efficient in covalent complex formation. Mutagenesis and x-ray crystallography approaches were used to identify the site of covalent crosslinking to be an allosteric cysteine residue. The subsequent application of this probe highlights the potential to selectively enrich the Dup enzymes from Legionella-infected cell lysates..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
bioRxiv.org - (2024) vom: 21. März Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kloet, Max S. [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2024.03.19.585531 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI042973201 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI042973201 | ||
| 003 | DE-627 | ||
| 005 | 20240322090728.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240320s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2024.03.19.585531 |2 doi | |
| 035 | |a (DE-627)XBI042973201 | ||
| 035 | |a (biorXiv)10.1101/2024.03.19.585531 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kloet, Max S. |e verfasserin |0 (orcid)0000-0002-8997-4412 |4 aut | |
| 245 | 1 | 0 | |a Development of covalent probes to capture<i>Legionella pneumophila</i>effector enzymes |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Upon infection of host cells,Legionella pneumophilareleases a multitude of effector enzymes into the cells cytoplasm that hijack a plethora of cellular activities, including the hosts ubiquitination pathways. Effectors belonging to the SidE-family are involved in non-canonical serine phosphoribosyl ubiquitination of host substrate proteins contributing to the formation of a Legionella-containing vacuole that is crucial in the onset of Legionnaires’ disease. This dynamic process is reversed by effectors called Dups that hydrolyse the phosphodiester in the phosphoribosyl ubiquitinated protein. We installed reactive warheads on chemically prepared ribosylated ubiquitin to generate a set of probes targeting these Legionella enzymes. In vitro tests on recombinant DupA revealed that a vinyl sulfonate warhead was most efficient in covalent complex formation. Mutagenesis and x-ray crystallography approaches were used to identify the site of covalent crosslinking to be an allosteric cysteine residue. The subsequent application of this probe highlights the potential to selectively enrich the Dup enzymes from Legionella-infected cell lysates. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Mukhopadhyay, Rishov |0 (orcid)0000-0002-8972-8983 |4 aut | |
| 700 | 1 | |a Mukherjee, Rukmini |0 (orcid)0000-0001-7955-6324 |4 aut | |
| 700 | 1 | |a Misra, Mohit |4 aut | |
| 700 | 1 | |a Jeong, Minwoo |4 aut | |
| 700 | 1 | |a Talavera Ormeño, Cami M. P. |0 (orcid)0000-0001-5502-2985 |4 aut | |
| 700 | 1 | |a Moutsiopoulou, Angeliki |4 aut | |
| 700 | 1 | |a Tjokrodirijo, Rayman T. N. |0 (orcid)0009-0007-4878-8385 |4 aut | |
| 700 | 1 | |a van Veelen, Peter A. |0 (orcid)0000-0002-7898-9408 |4 aut | |
| 700 | 1 | |a Shin, Donghyuk |0 (orcid)0000-0002-8272-6133 |4 aut | |
| 700 | 1 | |a Ðikić, Ivan |0 (orcid)0000-0001-8156-9511 |4 aut | |
| 700 | 1 | |a Sapmaz, Aysegul |0 (orcid)0000-0003-3942-7602 |4 aut | |
| 700 | 1 | |a Kim, Robbert Q. |0 (orcid)0000-0003-1834-8673 |4 aut | |
| 700 | 1 | |a van der Heden van Noort, Gerbrand J. |0 (orcid)0000-0001-5955-6431 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2024) vom: 21. März |
| 773 | 1 | 8 | |g year:2024 |g day:21 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2024.03.19.585531 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 21 |c 03 | ||